Summary

The global Bone Morphogenetic Protein (BMP) 2 market was valued at US$ 697 million in 2024 and is anticipated to reach US$ 1120 million by 2031, witnessing a CAGR of 6.77% during the forecast period 2025-2031.
North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 476.76 million in 2024 to reach $ 754 million by 2031, at a CAGR of 6.09% during the forecast period of 2025 through 2031.
Asia-Pacific market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 140.47 million in 2024 to reach $ 250.59 million by 2031, at a CAGR of 10.26% during the forecast period of 2025 through 2031.
The major global companies of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering, Cellumed, etc. In 2024, the world's top three vendors accounted for approximately 98.84% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Protein (BMP) 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Protein (BMP) 2.
The Bone Morphogenetic Protein (BMP) 2 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bone Morphogenetic Protein (BMP) 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone Morphogenetic Protein (BMP) 2 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
 Medtronic
 Jiuyuan Gene Engineering
 Cellumed

Segment by Type
 Sponge Carrier
 Hydroxyapatite Carrier

Segment by Application
 Spinal Fusion
 Trauma Surgery
 Oral Maxillofacial Surgery
 Reconstructive Surgery

Segment by Region
 North America
 U.S.
 Canada
 Mexico

 Asia-Pacific
 China
 South Korea
 Southeast Asia
 India

 Europe
 Germany
 France
 U.K.
 Italy
 Russia
 Rest of Europe

 South America
 Brazil

 Middle East & Africa
 Middle East
 Africa


Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031 2
1.2.2 Sponge Carrier 4
1.2.3 Hydroxyapatite Carrier 5
1.3 Market by Application 6
1.3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Growth by Application: 2020 VS 2024 VS 2031 7
1.3.2 Spinal Fusion 9
1.3.3 Trauma Surgery 10
1.3.4 Oral Maxillofacial Surgery 10
1.3.5 Reconstructive Surgery 11
1.4 Assumptions and Limitations 11
1.5 Study Objectives 12
1.6 Years Considered 13
2 Global Growth Trends 14
2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Perspective (2020-2031) 14
2.2 Global Bone Morphogenetic Protein (BMP) 2 Growth Trends by Region 15
2.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region: 2020 VS 2024 VS 2031 16
2.2.2 Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Region (2020-2025) 17
2.2.3 Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Region (2026-2031) 18
2.3 Bone Morphogenetic Protein (BMP) 2 Market Dynamics 19
2.3.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends 19
2.3.2 Bone Morphogenetic Protein (BMP) 2 Market Drivers 21
2.3.3 Bone Morphogenetic Protein (BMP) 2 Market Challenges 22
2.3.4 Bone Morphogenetic Protein (BMP) 2 Market Restraints 23
3 Competition Landscape by Key Players 24
3.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue 24
3.1.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue (2020-2025) 24
3.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2020-2025) 25
3.2 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Company Type by Company Type (Tier 1, Tier 2, and Tier 3) 25
3.3 Global Key Players Ranking by Bone Morphogenetic Protein (BMP) 2 Revenue 26
3.4 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio 27
3.4.1 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio (CR3 and HHI) 27
3.4.2 Global Top 3 Companies by Bone Morphogenetic Protein (BMP) 2 Revenue in 2024 28
3.5 Global Key Players of Bone Morphogenetic Protein (BMP) 2 Head office and Area Served 28
3.6 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Product and Application 29
3.7 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Date of Enter into This Industry 29
3.8 Mergers & Acquisitions, Expansion Plans 30
4 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Type 33
4.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Type (2020-2025) 33
4.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Type (2026-2031) 34
5 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Application 35
5.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Application (2020-2025) 35
5.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Application (2026-2031) 36
6 North America 37
6.1 North America Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031) 37
6.2 North America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031 37
6.3 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025) 38
6.4 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031) 38
6.5 United States 39
6.6 Canada 40
6.7 Mexico 41
7 Europe 42
7.1 Europe Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031) 42
7.2 Europe Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031 42
7.3 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025) 43
7.4 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031) 43
7.5 Germany 45
7.6 France 46
7.7 U.K. 47
7.8 Italy 48
7.9 Russia 49
8 Asia-Pacific 50
8.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031) 50
8.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Region: 2020 VS 2024 VS 2031 50
8.3 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2020-2025) 51
8.4 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2026-2031) 51
8.5 China 53
8.6 South Korea 54
8.7 Southeast Asia 54
8.8 India 55
9 South America 56
9.1 South America Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031) 56
9.2 South America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031 56
9.3 South America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025) 57
9.4 South America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031) 57
9.5 Brazil 58
10 Middle East & Africa 59
10.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031) 59
10.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031 59
10.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025) 60
10.4 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031) 60
10.5 Middle East 61
10.6 Africa 62
11 Key Players Profiles 63
11.1 Medtronic 63
11.1.1 Medtronic Company Details 63
11.1.2 Medtronic Business Overview 63
11.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Introduction 64
11.1.4 Medtronic Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025) 66
11.1.5 Medtronic Recent Development 67
11.2 Jiuyuan Gene Engineering 68
11.2.1 Jiuyuan Gene Engineering Company Details 68
11.2.2 Jiuyuan Gene Engineering Business Overview 69
11.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Introduction 70
11.2.4 Jiuyuan Gene Engineering Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025) 71
11.3 Cellumed 72
11.3.1 Cellumed Company Details 72
11.3.2 Cellumed Business Overview 72
11.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Introduction 73
11.3.4 Cellumed Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025) 74
12 Analyst's Viewpoints/Conclusions 75
13 Appendix 77
13.1 Research Methodology 77
13.1.1 Methodology/Research Approach 77
13.1.2 Data Source 80
13.2 Author Details 83
13.3 Disclaimer 84